Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy

Volume: 141, Issue: 15, Pages: 1214 - 1224
Published: Apr 14, 2020
Abstract
Background: In patients with transthyretin amyloid cardiomyopathy, tafamidis reduces all-cause mortality and cardiovascular hospitalizations and slows decline in quality of life compared with...
Paper Details
Title
Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy
Published Date
Apr 14, 2020
Volume
141
Issue
15
Pages
1214 - 1224
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.